Skip to main content
Clinical Trials/CTRI/2019/09/021080
CTRI/2019/09/021080
Not yet recruiting
未知

A prospective study to evaluate the Adverse Drug Reactions and to assess quality of life in prostate cancer patients receiving docetaxel in Tata Memorial Centre.

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C61- Malignant neoplasm of prostate
Sponsor
Tata Memorial Centre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient of either gender aged 18 or more than 18
  • 2\. Metastatic Prostate Carcinoma patients receiving docetaxel chemotherapy.

Exclusion Criteria

  • 1\. Patient not willing to give consent.
  • 2\. Patients having non\-compliance to the treatment schedule at Tata memorial Hospital or ACTREC.

Outcomes

Primary Outcomes

Not specified

Similar Trials